Dirk Dechering (@DocDirkules) header
Dirk Dechering (@DocDirkules) profile picture

Head of Electrophysiology, Niels Stensen Kliniken, Former consultant cardiologist @uk_muenster

Marienhospital Osnabrück
Joined December 2019
Photo by Dirk Dechering (@DocDirkules)Photo by Dirk Dechering (@DocDirkules)Photo by Dirk Dechering (@DocDirkules)Photo by Dirk Dechering (@DocDirkules)Photo by Dirk Dechering (@DocDirkules)Photo by Dirk Dechering (@DocDirkules)Photo by Dirk Dechering (@DocDirkules)Photo by Dirk Dechering (@DocDirkules)Photo by Dirk Dechering (@DocDirkules)Photo by Dirk Dechering (@DocDirkules)
Dirk Dechering retweeted
🔥 Hot off the press: We identified how and where AF begins. I am excited to share this work. Since the discovery of PV triggers more than 25 years ago, AF ablation has evolved into an empiric therapy centered on PVI. Yet, we have never been able to identify the arrhythmogenic substrate that determines why a premature beat initiates AF at one site and not another. We believe this study changes that. In this mechanistic study, we found that AF initiation arose predominantly through reentry originating from a small number of spatially discrete regions with steep repolarization gradients. Their distribution was unique to each patient, and they accounted for more than 92% of AF initiation episodes. Importantly, the arrhythmogenic substrate was not defined by low voltage, and while conduction abnormalities were often present, they appeared to play a secondary role. Its patient-specific distribution may help explain the controversy surrounding posterior wall isolation: the posterior wall harbored the substrate in only approximately 30% of patients. Importantly, in redo patients with durable PVI, right-atrial substrate (which is often beyond standard mapping strategies) was identified in 30%. Most encouragingly, in an exploratory cohort of 24 patients with recurrent AF and durable PVI (50% PerAF), targeted elimination of these sites achieved 87.5% single-procedure freedom from any atrial tachyarrhythmia over a median of 489 days, without antiarrhythmic drugs. The thoughtful accompanying editorial by Jon Kalman highlights the significance of this discovery and its central translational challenge of bringing it into real-world clinical practice. But stay tuned! Technology is under development to transform this discovery into a rapid, automated functional mapping. Current electroanatomic mapping relies largely on voltage amplitude and activation timing. We need to move beyond these measures and map how tissue actually functions - how it conducts, repolarizes, and responds to premature stimulation. This can add the critical dimension that has long been missing from substrate mapping and may reveal what truly makes cardiac tissue arrhythmogenic. To me, this is the beauty of physiology: there are no black boxes. We can identify the sites that reproducibly initiate the arrhythmia, define their EP properties, eliminate them with ablation, and confirm that arrhythmia can no longer be initiated. The next steps are prospective multicenter validation and technological development. Together, they may move AF ablation beyond empiric therapy toward truly individualized, mechanism-guided therapy. 📄 Paper in @JACCJournals: doi.org/10.1016/j.jacep.2026… 📝 Editorial: doi.org/10.1016/j.jacep.2026… #JACCCEP #AtrialFibrillation #CardiacElectrophysiology #CatheterAblation #EPeeps
16
159
4
441
53,397
Dirk Dechering retweeted
In patients with ischemic stroke and concurrent nonvalvular atrial fibrillation and ASCVD, adding an antiplatelet agent to anticoagulant therapy offered no net clinical benefit over anticoagulant monotherapy. ja.ma/4b3mJX6
2
34
96
7,638
Dirk Dechering retweeted
Original Article: Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes (NEO-MINDSET trial) nej.md/3VeTJT8 Editorial: Discontinuation of Aspirin in Acute Coronary Syndromes Treated with Coronary-Artery Stents nej.md/3XJpxAK #Cardiology
1
36
5
145
46,106
Dirk Dechering retweeted
For scar-related VTs, the exit predicted from a vector-based #QRS algorithm often differs from the location where ablation terminates the VT. This is an important consideration for use of the QRS to guide VT ablation strategies. jacc.org/doi/10.1016/j.jacep… #JACCCEP #epAblation
49
124
11,114
Dirk Dechering retweeted
Programmed ventricular stimulation for risk stratification in patients with myocardial scarring and mildly reduced or preserved ejection fraction #OpenAccess heartrhythmjournal.com/artic…
12
2
37
9,313
OCEAN just published in NEJM. In AF patients >1 yr after successful ablation, rivaroxaban did not reduce stroke/systemic embolism/new covert infarcts vs aspirin (0.31 vs 0.66 events/100 pt-yrs; P=0.28). Bleeding higher with rivaroxaban (1.6% vs 0.6%). nejm.org/doi/full/10.1056/NE…
3
42
2
112
12,459
Dirk Dechering retweeted
📌 ALONE_AF Trial 👉 Stopping oral #anticoagulation 1y after successful AF #ablation 🔷 Does not ⬆️ the risk of ischemic #stroke 🔷⬇️ the risk of major #bleeding #EPeeps #WomeninEP #afib #CardioTwitter #MedTwitter @drjohnm @natale_md @TJaredBunch @DhirajGuptaBHRS @DrJasonAndrade
2
31
1
83
6,635
Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial: @ESC_Journals 🥸Aspirin for primary prevention for older pts = MACE! 👇👇👇👇
10
197
6
671
125,185
Dirk Dechering retweeted
Distribution of left ventricular scar in different cardiomyopathies 📚
1
66
1
276
29,461
Here is the video of PFA delivered near a LAA occlusion device
Visible Arcing Observed with Pulsed Field Ablation Applications Delivered Near a Left Atrial Appendage Occlusion Device - Heart Rhythm heartrhythmjournal.com/artic…
13
124
6
321
97,300
Distribution of LV scar in different cardiomyopathies 📚 JACC Advances 2024 ♥️
1
63
256
24,337
⚡️Latest #EUROPACE #Dronedarone provides effective early rhythm control: post-hoc analysis of the ATHENA trial using EAST-AFNET 4 criteria 📑doi.org/10.1093/europace/eua… @GiulioConte9 @Dominik_Linz @FraSantoroMD @AndyZhangMD @DavideMei93 @marcovitoloMD @LuigiDiBiaseMD
12
26
1,559
Dirk Dechering retweeted
Pulmonary vein isolation (PVI) in persistent AF: not sufficient and possibly not always necessary. Durable PVI increases freedom from AF only in paroxysmal but not in persistent AF @Tardu_Oezkartal @Mbergonti #AHAJournals #Epeeps doi.org/10.1161/CIRCEP.124.0…
1
31
1
88
7,076
Dirk Dechering retweeted
New research reveals that atrial fibrillation impairs brain glymphatic function, which is crucial for clearing toxins and maintaining cognitive health. Read more in #EHJ. doi.org/10.1093/eurheartj/eh… #AF #cognitive #cardiotwitter @ESC_Journals @escardio
2
26
1
54
6,254
Dirk Dechering retweeted
🚨Latest #FreeRead Article in @JICE_EP Correlation Between Diagnosis-to-Ablation Time & Atrial Fibrillation Recurrence: a Systematic review & Meta-analysis 🧐📖rdcu.be/eaXQv by Muhammad Arslan Ul Hassan, Sana Mushtaq, Tao Li, Zhen Yang, Abdul Rehman & Al-qaisi Mohammed Abdulkarem #EPeeps
4
10
1,389
Dirk Dechering retweeted
Impact of horizontal rotation on electrocardiogram
2
86
5
407
47,219
Dirk Dechering retweeted
🔴Atlas of Regional Left Ventricular Scar in Nonischemic Cardiomyopathies: Substrates and Etiologies⤵️State-of-the-Art #2024Review #OpenAccess 🔹sciencedirect.com/science/ar… #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros
62
1
203
29,041
Dirk Dechering retweeted
PVI using thermal ablation energy results in significant sustained changes in the heart rate parameters related to autonomic function. These changes are independent of ablation technology employed & are associated w/ procedural success jacc.org/doi/10.1016/j.jacep… #JACCCEP #AFib
1
9
33
4,763
Dirk Dechering retweeted
#JACCCEP multicenter RCT shows that CSI in addition to PVI & roofline ablation for first-time procedures in a small population of pts w/ paroxysmal & early persistent #AFib does not reduce AF recurrence after 2 yrs follow-up jacc.org/doi/10.1016/j.jacep… @JonathanAriya @PrashSanders
15
2
30
12,510